Apricus Biosciences Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
2,511.00
9,259.00
4,839.00
-
-
Cost of Goods Sold (COGS) incl. D&A
2,631.00
918.00
922.00
106.00
117.00
Gross Income
120.00
8,341.00
3,917.00
106.00
117.00
SG&A Expense
18,677.00
32,706.00
25,165.00
13,552.00
10,556.00
EBIT
18,797.00
24,365.00
-
-
10,673.00
Unusual Expense
534.00
1,674.00
3,236.00
7,479.00
1,068.00
Non Operating Income/Expense
3,120.00
553.00
116.00
36.00
75.00
Interest Expense
727.00
339.00
895.00
1,444.00
83.00
Pretax Income
15,870.00
22,477.00
19,023.00
7,659.00
11,749.00
Consolidated Net Income
15,870.00
22,477.00
19,023.00
7,659.00
11,749.00
Net Income
15,870.00
22,477.00
19,023.00
7,659.00
11,749.00
Net Income After Extraordinaries
14,802.00
23,168.00
19,023.00
7,885.00
23,819.00
Net Income Available to Common
15,735.00
21,786.00
19,023.00
7,433.00
11,996.00
EPS (Basic)
4.90
5.50
3.83
1.15
0.02
Basic Shares Outstanding
3,441.30
3,954.00
4,972.90
6,517.00
11,892.00
EPS (Diluted)
4.92
5.51
3.83
1.14
0.03
Diluted Shares Outstanding
3,441.30
3,954.00
4,972.90
6,517.00
11,892.00
EBITDA
18,720.00
24,195.00
20,948.00
13,552.00
10,556.00
About Apricus Biosciences
View Profile
